Home › Compare › KXINW vs MRK

KXINW vs MRK: Dividend Comparison 2026

KXINW yields 222222.22% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KXINW wins by $1.4076447531278624e+30M in total portfolio value
10 years
KXINW
KXINW
● Live price
222222.22%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4076447531278624e+30M
Annual income
$1,406,399,782,569,334,400,000,000,000,000,000,000.00
Full KXINW calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KXINW vs MRK

📍 KXINW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKXINWMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KXINW + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
KXINW pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KXINW
Annual income on $10K today (after 15% tax)
$18,888,888.89/yr
After 10yr DRIP, annual income (after tax)
$1,195,439,815,183,934,200,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KXINW beats the other by $1,195,439,815,183,934,200,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KXINW + MRK for your $10,000?

KXINW: 50%MRK: 50%
100% MRK50/50100% KXINW
Portfolio after 10yr
$7.038223765639312e+29M
Annual income
$703,199,891,284,667,200,000,000,000,000,000,000.00/yr
Blended yield
99.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KXINW
No analyst data
Altman Z
-38.0
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KXINW buys
0
MRK buys
0
No recent congressional trades found for KXINW or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKXINWMRK
Forward yield222222.22% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$1.4076447531278624e+30M$56.8K ✓
Annual income after 10y$1,406,399,782,569,334,400,000,000,000,000,000,000.00 ✓$9,798.13
Total dividends collected$1.4075632434891558e+30M$28.9K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KXINW vs MRK ($10,000, DRIP)

YearKXINW PortfolioKXINW Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$22,232,922$22,222,222.22$11,206$366.19+$22.22M → KXINW
2$46,198,082,523$46,174,293,296.41$12,650$502.35+$46198.07M → KXINW
3$89,718,752,943,223$89,669,320,994,923.30$14,407$694.19+$89718752.93M → KXINW
4$162,845,393,609,755,680$162,749,394,544,106,430.00$16,585$967.82+$162845393609.74M → KXINW
5$276,249,735,879,778,500,000$276,075,491,308,616,120,000.00$19,342$1,363.89+$276249735879778.47M → KXINW
6$437,989,462,258,048,500,000,000$437,693,875,040,657,100,000,000.00$22,913$1,947.19+$437989462258048512.00M → KXINW
7$649,026,142,700,674,900,000,000,000$648,557,493,976,058,700,000,000,000.00$27,662$2,823.89+$649026142700674875392.00M → KXINW
8$898,874,153,179,794,200,000,000,000,000$898,179,695,207,104,400,000,000,000,000.00$34,159$4,173.35+$8.988741531797941e+23M → KXINW
9$1,163,523,886,474,633,300,000,000,000,000,000$1,162,562,091,130,731,000,000,000,000,000,000.00$43,337$6,308.80+$1.1635238864746333e+27M → KXINW
10$1,407,644,753,127,862,300,000,000,000,000,000,000$1,406,399,782,569,334,400,000,000,000,000,000,000.00$56,776$9,798.13+$1.4076447531278624e+30M → KXINW

KXINW vs MRK: Complete Analysis 2026

KXINW — Stock

As of June 25, 2021, Kaixin Auto Holdings was acquired by Haitaoche Limited (Cayman), in a reverse merger transaction. Kaixin Auto Holdings operates as a used car dealership in the People's Republic of China. As of December 31, 2020, the company had 14 dealerships. It also provides financing channels to its customers through its partnership with financial institutions; and value-added services to its customers, including insurance, extended warranties, and after-sales services. The company was founded in 2015 and is headquartered in Beijing, the People's Republic of China.

Full KXINW Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KXINW vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KXINW vs SCHDKXINW vs JEPIKXINW vs OKXINW vs KOKXINW vs MAINKXINW vs JNJKXINW vs ABBVKXINW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.